.jpg)
Delirium is an acute neurocognitive disorder that affects a significant proportion of hospitalized patients, especially in intensive care units and geriatrics. Its early detection remains a clinical challenge due to its fluctuating presentation and care overload. Artificial intelligence offers a promising avenue to support diagnosis, but its effective integration requires user-centered design for medical professionals. In this context, companies like Q2BSTUDIO develop AI for businesses that combine interpretable algorithms with clinical judgment, improving accuracy and trust in predictive tools.
A recent approach combines interactive machine learning with physician oversight, allowing clinical features to be refined and models validated with real data from multiple hospitals. This methodology uses SHAP value-based explanations to ensure transparency in AI decisions. The synergy between healthcare professionals and custom software systems enables the creation of tailored applications that adapt to hospital workflows, integrating artificial intelligence, AWS and Azure cloud services for data processing, and business intelligence tools such as Power BI for indicator visualization. Furthermore, cybersecurity is crucial to protect sensitive information, and AI agents can automate early alerts. Q2BSTUDIO offers business intelligence services and AI solutions for companies that materialize this human-machine collaboration in real clinical environments.
